Other headlines:Siemens installs first U.S. FlashTomoTherapy plans financial restatementHenry Ford expands Zonare base
The Mayo Clinic in Rochester, MN, is the first medical facility in the U.S. to begin operating Siemens' latest CT product, the Somatom Definition Flash. The scanner, unveiled late last year, offers dual-source x-ray beams yet minimizes patient exposure to radiation. A spiral heart scan exposes the patient to less than 1 mSv. Such scans typically expose patients to between 8 mSv and 20 mSv, according to the company. The Flash is also very quick, completing a scan of the entire chest in 0.6 seconds.
Financial statements filed by radiotherapy specialist TomoTherapy for 2008 are wrong and must be corrected. The company notified the Securities and Exchange Commission that its Form 10-K annual report filed March 12 and amended April 1 "should not be relied upon due to errors in such financial statements relating to the accounting for income taxes, including a potential overstatement of the valuation allowance." The company is currently investigating the identified errors and their underlying causes, according to a Form 8-K filing with the SEC. TomoTherapy has informed the SEC that it intends to file an amendment to its 2008 Form 10-K containing restated financial statements for 2008.
Web-based Opal-RAD PACS from Viztek can now acquire, manage, and integrate imaging studies from multiple PACS made by other vendors into a single enterprise work list, automatically sending reports back to the original PACS for storage. This new functionality enables radiology groups reading for multiple facilities and enterprises running multiple PACS to communicate and work with each other as if they were functioning in a single PACS environment, according to the company.
Henry Ford Health System has purchased five more ultrasound scanners made by Zonare and ordered another two. When all are in place, the Detroit-based healthcare system will have an installed base of 11 Zonare scanners.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.